Section I: Contracting authority
I.1)Name, addresses and contact point(s)
Bio Products Laboratory Limited
For the attention of: Leanne Bull
WD6 3BX Elstree
Telephone: +44 2089572444
Fax: +44 2089572610
General address of the contracting authority: www.bpl.co.uk
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
I.2)Type of the contracting authority
Body governed by public law
I.4)Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: no
Section II: Object of the contract
II.1.1)Title attributed to the contract by the contracting authority:
Packaging outsourcing project.
II.1.2)Type of contract and location of works, place of delivery or of performance
Service category No 27: Other services
NUTS code UKH23
II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves a public contract
II.1.4)Information on framework agreement
II.1.5)Short description of the contract or purchase(s)
To receive unlabeled biological glass vials along with cartons, labels and leaflets. To pack labelled vials into carton along with leaflet. Apply anti counterfeiting devices. Provide serialisation coding (2D Barcode) via encrypted server. Return filled cartons to BPL with batch documentation for Finished Product release.
II.1.6)Common procurement vocabulary (CPV)
II.1.7)Information about Government Procurement Agreement (GPA)
The contract is covered by the Government Procurement Agreement (GPA): no
This contract is divided into lots: no
II.1.9)Information about variants
Variants will be accepted: no
II.2)Quantity or scope of the contract
II.2.1)Total quantity or scope:
II.2.2)Information about options
II.2.3)Information about renewals
II.3)Duration of the contract or time limit for completion
Duration in months: 48 (from the award of the contract)
Section III: Legal, economic, financial and technical information
III.1)Conditions relating to the contract
III.1.1)Deposits and guarantees required:
Parent company guarantee.
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
Net 30 days.
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:
Public Limited Company.
III.1.4)Other particular conditions
The performance of the contract is subject to particular conditions: no
III.2)Conditions for participation
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers
III.2.2)Economic and financial ability
Information and formalities necessary for evaluating if the requirements are met: 3 years audited accounts
Information and formalities necessary for evaluating if the requirements are met:
MHRA and or FDA approved packing facility.
Proven experience of packing pharmaceutical products (3 years at least).
Ability to deal with clinical trials and commercial packing.
Flexible capability able to deal effectively with batch size from 1 700 vials to 20 000 vials per batch covering 10ml glass vials up to 500 ml bottles vials.
Ability to cope with multiple items in pack – WFI vials and kits.
2°C to 8°C storage.
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts
III.3.1)Information about a particular profession
Execution of the service is reserved to a particular profession: no
III.3.2)Staff responsible for the execution of the service
Legal persons should indicate the names and professional qualifications of the staff responsible for the execution of the service: no
Section IV: Procedure
IV.1)Type of procedure
IV.1.1)Type of procedure
Justification for the choice of accelerated procedure: This tender is required on a fast track basis due to the urgency of the business to achieve operational efficiencies which will improve our ability to provide life saving drugs that accommodate the requirements of regulatory pressures to add track & trace, serialisation and 2D bar codes.
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate
Envisaged minimum number 5: and maximum number 10
IV.1.3)Reduction of the number of operators during the negotiation or dialogue
The most economically advantageous tender in terms of the criteria stated below
1. Experience in packing of Pharma products as in description. Weighting 20
2. Pharma knowledge. Weighting 20
3. MHRA / FDA approval. Weighting 10
4. Cost. Weighting 10
5. Future proof technology. Weighting 40
IV.2.2)Information about electronic auction
An electronic auction will be used: no
IV.3.1)File reference number attributed by the contracting authority:
IV.3.2)Previous publication(s) concerning the same contract
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate
5.4.2012 – 17:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up
IV.3.7)Minimum time frame during which the tenderer must maintain the tender
IV.3.8)Conditions for opening tenders
Section VI: Complementary information
VI.1)Information about recurrence
This is a recurrent procurement: yes
Estimated timing for further notices to be published: Every 48 months.
VI.2)Information about European Union funds
VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures
VI.4.2)Lodging of appeals
VI.4.3)Service from which information about the lodging of appeals may be obtained
VI.5)Date of dispatch of this notice: